HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,046,104 | +6.8% | 184,453 | +0.8% | 0.01% | 0.0% |
Q2 2023 | $6,597,599 | +22.2% | 182,911 | +29.4% | 0.01% | +20.0% |
Q1 2023 | $5,397,049 | -29.4% | 141,321 | +5.1% | 0.01% | -28.6% |
Q4 2022 | $7,648,043 | +8.5% | 134,412 | -24.6% | 0.01% | 0.0% |
Q3 2022 | $7,049,000 | -8.6% | 178,261 | +1.7% | 0.01% | -12.5% |
Q2 2022 | $7,716,000 | +16.4% | 175,354 | +5.5% | 0.01% | +33.3% |
Q1 2022 | $6,631,000 | +4.5% | 166,275 | +4.3% | 0.01% | +20.0% |
Q4 2021 | $6,346,000 | -1.1% | 159,421 | -0.3% | 0.01% | -16.7% |
Q3 2021 | $6,416,000 | -38.8% | 159,859 | -30.8% | 0.01% | -33.3% |
Q2 2021 | $10,480,000 | +17.9% | 231,062 | +8.4% | 0.01% | +12.5% |
Q1 2021 | $8,886,000 | +39.9% | 213,155 | +43.3% | 0.01% | +14.3% |
Q4 2020 | $6,353,000 | +64.8% | 148,756 | +1.4% | 0.01% | +40.0% |
Q3 2020 | $3,856,000 | +27.6% | 146,750 | +30.2% | 0.01% | +25.0% |
Q2 2020 | $3,022,000 | +110.6% | 112,750 | +41.4% | 0.00% | +100.0% |
Q1 2020 | $1,435,000 | +77.2% | 79,750 | +99.4% | 0.00% | +100.0% |
Q4 2017 | $810,000 | +831.0% | 40,000 | +263.6% | 0.00% | – |
Q2 2013 | $87,000 | – | 11,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |